Waleed H. Hassanein - Aug 11, 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: President & CEO, Director
Signature: By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol: TMDX
Transactions as of: Aug 11, 2022
Transactions value $: -$940,301
Form type: 4
Date filed: 8/15/2022, 05:50 PM
Previous filing: Aug 9, 2022
Next filing: Aug 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Sale	-$604K	-12.9K	-2.55%	$46.74	493K	Aug 11, 2022	Direct	F1, F2
transaction	TMDX	Common Stock	Sale	-$336K	-7K	-1.42%	$48.00	486K	Aug 12, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a sale of shares of common stock to generate cash for the payment of taxes, including estimated taxes, due as a result of the vesting or settlement of certain equity-based awards or the exercise of stock options as permitted by the lock-up agreement, dated August 3, 2022, among the Reporting Person, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Cowen and Company, LLC as the representatives of the underwriters named therein.
F2	The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $46.39 to $47.26, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Content

Represents a sale of shares of common stock to generate cash for the payment of taxes, including estimated taxes, due as a result of the vesting or settlement of certain equity-based awards or the exercise of stock options as permitted by the lock-up agreement, dated August 3, 2022, among the Reporting Person, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Cowen and Company, LLC as the representatives of the underwriters named therein.

The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $46.39 to $47.26, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.